SHINE and Phoenix have completed a 132-hour test of the high-flux Phoenix neutron generator that helps to prove the performance and reliability of Phoenix’s neutron generator technology and SHINE’s medical isotope production process, the companies announced recently.

“This delivery represents the culmination of over a decade of joint development effort between SHINE and Phoenix, moving from proof of concept, to proof of scale and now to a unit that can produce millions of doses of medicine per year when paired with SHINE’s proprietary isotope production system,” SHINE CEO Greg Piefer said in a statement.

According to a release, Phoenix’s second-generation neutron generator prototype operated in SHINE’s facility with an average neutron yield that was 10 percent higher than required and uptime higher than 99%.

SHINE will be receiving eight production neutron generators from Phoenix for installation over the next two years.